We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Diagnostic Techniques Compared for Malaria Diagnosis

By LabMedica International staff writers
Posted on 13 Sep 2018
Malaria is an overwhelming problem in tropical developing countries. More...
It is currently the most important human parasitic disease in the world and continues to be a serious public health problem.

Appropriate diagnostic methods are essential for early detection. Microscopy examination of blood films remains the gold standard, although molecular techniques have higher sensitivity and are very useful in cases of low parasitaemia and mixed infections.

Medical scientists working with those at the Hospital Universitario 12 de Octubre (Madrid, Spain) carried out a prospective, observational, multicenter study that was performed at five different hospitals in Madrid, Spain, between January 2015 and April 2017. All participants were immigrants from malaria-endemic areas, who were divided into two groups: asymptomatic group and symptomatic. A 5mL blood sample was collected from all participants.

All the samples were tested using all the diagnostic techniques: rapid diagnostic technique, Giemsa-stained thin and thick blood films, the commercial polymerase chain reaction technique under evaluation, and the reference molecular technique (CNM-PCR).

The team found that for the 250 patients included in the study: 164 (65.6%) in the asymptomatic group, and 86 (34.4%) in the symptomatic group. There were seven cases of asymptomatic parasitaemia (prevalence = 2.8%) that were detected only by molecular methods. In the symptomatic group, there were seven cases of submicroscopic malaria. The main species detected was Plasmodium falciparum (96.6%). The commercial molecular technique had higher sensitivity of 96% than the other methods and a high rate of concordance with the in-house reference PCR technique.

The authors concluded that The FTD-Malaria and Malaria Differentiation PCRs showed good test values for the diagnostic test parameters (sensitivity, specificity, positive and negative predictive values and likelihood ratios), as well as good inter-procedure agreement for detecting malaria infections. The study was published on August 29, 2018, in the Malaria Journal.

Related Links:
Hospital Universitario 12 de Octubre



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Electrolyte Analyzer
BKE-B
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.